Objective
Hand and wrist Musculo-skeletal Disorders, largely originated by pathologies such as arthritis or stroke, are more and more frequent. There are around 107,5M people reportedly suffering from any type of hand-related MSDs in the EU and the USA and the number is expected to grow by nearly 50% until 2030. This type of disease is cause of huge limitations and pain and a strong negative influence in the patients quality of life.
NUADA was founded in 2014 to solve this problem by bringing to market an award-winning patent-pending glove that prevents and compensates manipulation disabilities. The gloves beyond state-of-the-art technology is composed by special built-in bioinspired artificial tendons that support the hand when functionally required and are connected to a patented system that is worn on the users’ wrist.
In addition to the hand function support, the NUADA glove is equipped with tracking components that collect users’ metrics and shares the data with the user and/or healthcare professionals.
We have successfully raised over 600k€ of funding and nearly 1M€ in public funding for R&D, having obtained recognition by some of the world’s most relevant innovation awards and accelerators such as the Microsoft Imagine Cup, the HAX accelerator and TechCrunch.
Due to the immense variety of potential applications for our technology we have defined labour related injury prevention as our beachhead market (i.e. in the manufacturing and retail sectors) while simultaneous aiming for an entry in the more regulated, but highly promising, healthcare market.
NUADA’s customers get a more intelligent, more capable, user-friendly, seamlessly wearable glove for about one quarter of the price of the most competitive alternative.
The successful market entry of the NUADA glove will mean injury prevention, fatigue relief, increased job safety and hand mobility, in sum, a better health and life quality for its users.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine rheumatology
- social sciences economics and business business and management business models
- medical and health sciences basic medicine pathology
- medical and health sciences basic medicine neurology stroke
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.2.1.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
SME-1 - SME instrument phase 1
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-SMEInst-2016-2017
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
4700 312 Braga
Portugal
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.